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Abstract
Role of Translation Initiation in Regulation of Epithelial Junctions and Cell Motility
By Fahda Fawaz Alsharief, Master of Science
This thesis is submitted in partial fulfillment of the requirements for the Master of Science
degree at Virginia Commonwealth University.
Virginia Commonwealth University, 2017
Thesis Director: Dr. Andrei Ivanov, Professor, Department of Human and Molecular Genetics

The integrity and barrier properties of intestinal epithelium are determined by specialized
adhesive structures known as intercellular junctions; composed of adherens junctions (AJs), tight
junctions (TJs) and focal adhesions that mediate cell-cell and cell matrix interactions,
respectively. These two types of epithelial cell adhesions regulate each other during disruption
and restitution of the epithelial barrier. Inflammatory cytokines such as interferon gamma (IFNγ)
and tumor necrosis factor alpha (TNFα) are elevated during intestinal inflammation. The most
notable effects of IFNγ and TNFα on intestinal epithelial homeostasis involve disruption of
apical junctions and attenuation of cell migration. Although molecular mechanisms underlying
these effects remain poorly understood, expressional downregulation of different adhesion
proteins may play a major role in the cytokine-dependent disruption of the intestinal epithelial
barriers. This thesis is based on the hypothesis that inhibition of the protein translation initiation
machinery promotes the disruption of the intestinal epithelial barrier and attenuates epithelial
restitution during mucosal inflammation. This study was focused on two eukaryotic translation
initiation factors, eIF4G1 and eIF4G2, which play essential roles in the regulation of capdependent protein translation. Expression of both translation initiation factors was dramatically
downregulated in model intestinal epithelial cell monolayers treated with IFNγ and TNFα in
parallel to cytokine-induced disruption of the epithelial barrier. siRNA or shRNA-mediated
downregulation of either eIF4G1, or eIF4G2 increased permeability of well-differentiated SKCO15 intestinal epithelial cell monolayers and decreased expression of different adherens
junction and tight junction proteins. Furthermore depletion of these translation initiating factors
inhibits different modes of migration (wound healing and transfilter migration) of stem-cell like
xi

and well-differentiated intestinal epithelial cells.

These findings suggest that eukaryotic

translation initiation factors of the eIF4G family play unique roles in regulating integrity and
restitution of the intestinal epithelial barrier. Downregulation of these translation initiating
factors may mediate disruption of the intestinal epithelial barriers during mucosal inflammation.

xii

1. INTRODUCTION

1.1 Role of Intracellular Junctions
Intercellular junction plays a crucial role by forming the barriers and keeping the tissue integrity
in a multicellular organism. Epithelial barriers protect the body interior of mammalian species
from external environments, and working as defending line between invading pathogens and the
immune system of the host. This is true in the gastrointestinal tract, especially in the intestines,
where the epithelial barrier plays a vital role in transporting nutrients and water, and preventing
contamination which results from microbial intestinal tissues [5, 6]. As mentioned before the
epithelial barrier is formed by intercellular junctions which are created by plasma membrane.
Intercellular junctions are composed of scaffolding and adhesive proteins that are attached to
different types of cytoskeletal structures such as microtubules, actin filaments, and intermediate
filaments. These intercellular adhesive structures include various types of junctions: Tight
Junctions (TJ), Adherens Junctions (AJ), Gap Junctions (GJ), and Desmosomes [7]. AJs, TJs,
and desmosome are the more abundant junctions present in the apical side of the epithelia; these
together form what is called apical junction complex (AJC) [7, 8]. The AJC maintains the
characteristic of the epithelia by controlling permeability, polarity, adhesion and cell growth [9].
Both TJ and AJ are composed of transmembrane proteins and peripheral membrane proteins.
Transmembrane proteins involve claudins, occludin, JAM-A, cadherin, and nectin, which are
involved in homotypical trans-interaction. Whereas, peripheral membrane proteins ‘cytosolic
plaque’ consists of the catenin, afadin and “zonula occludens” (ZO) family of proteins which
stabilize the adhesive component of the AJC [7, 10]. Epithelial barrier is disrupted during the
acute inflammatory phase thus amplifying inflammation, while the barrier is restored during the
remission step, which helps to reduce inflammatory events [7]. The invading pathogenic
microorganisms release a variety of agents which disrupt the epithelial barriers on the apical side
of epithelial layers, such as, bacterial lipopolysaccharide, poreforming toxins, and cytoskeleton
modifying proteins. However, on basal side, the barrier disruption will be increased by moving
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activated immune cells to sites of pathogen invasion. The epithelial permeability will be
increased by releasing reactive oxygen species (ROS) and proteases, or by secreting
proinflammatory cytokines—such as, tumor necrosis factor (TNF), interleukin (IL), and
interferon (IFN)—through mucosal immune cells. Increasing the permeability of the epithelial
barrier is well-documented in different immune diseases and gastrointestinal diseases, such as
inflammatory bowel disease (IBD), irritable bowel syndrome, gastric ulcer, celiac disease, food
allergies, asthma, sepsis, cancer (esophagus, and colorectal) and type 1 diabetes [11, 12].
Accordingly, understanding the mechanisms that control the disruption of epithelial barrier is the
main key to investigate molecular targets of mucosal inflammation.

Fig 1.1: - Important Components of Intercellular Junctions in Mammalian Cells.
Intercellular adhesions are mediated by specialized plasma membrane structures termed junctions; TJ, AJ, GJ
and, Desmosomes. Adapted from Tsukita S. Nat Rev Mol Cell Biol, 2001
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1.2 Molecular Compositions of Epithelial Junctions
1.2.1 Tight Junction
TJs are present in all types of epithelial cells, involving epithelial and endothelial cells. They are
placed next to AJs in the most apical part of junctional complexes of epithelial cells [13]. Under
the electron microscopy, TJs appear as zones of adjacent intercellular contacts sealing the
paracellular space [11]. The TJs play the key role in regulating the movement of ions and solutes
intercellularly and intracellularly [10]. They also establish the apico-basal cell polarity, and
create the paracellular barrier [11]. Permeability and permselectivity are the main functions of
TJs which can be determined in the lab by specific experiments. Permeability is a quantitative
characteristic of TJs which can be measured by transepithelial electrical resistance (TEER),
while the permselectivity is a qualitative feature of TJs which determines the transports of either
cations or anions. For example, gastrointestinal epithelia classified depending on their
permeability on three main categories: leaky, moderately, and tight. Leaky epithelium, which
presents in the small intestine, has TEER under 200 W cm2. Moderately leaky epithelium, which
found in colon, has TEER between 300-1000 W cm2. Whereas, tight epithelium barrier has
TEER above 1000 W cm and presents esophagus. To study the regulation of TJs in vitro, human
colonic carcinoma derived epithelial cell lines can be used. For instance, Caco 2 cells can be
used to study the moderately leaky, while T84 and SK CO15 have been used to study tight
barriers [11].
As many intercellular junctions, the molecular composition of TJs have been identified as
transmembrane proteins (integral membrane proteins), and peripheral membrane proteins
(cytoplasmic scaffolding plaque). The transmembrane proteins, which mediate cell‑cell
adhesions and create the paracellular barrier, consist of major types of integral proteins: claudin
family; tight junction‑associated MARVEL proteins (TAMP) family which includes occludin,
tricellulin, and marvelD3; and immunoglobulin‑like proteins such as junctional adhesion
molecule (JAM)‑A and coxsackievirus and adenovirus receptor (CAR)[11].
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Occludin and claudin are considered as a core of TJ and regulate the permeability and selectivity
of paracellular pathway of ions between adhering cells [10, 11, 13]. The peripheral membrane
proteins, which form cytosolic scaffolding plaque and regulate TJ stability and remodeling, have
five molecular component proteins: Zonula occluden family (ZO-1, ZO-2, ZO-3), cinguilin, and
afadin. Zonula occluden family is considered as prototypical components of the cytosolic plaque
of TJ and has membrane-associated guanylate kinase (MAGUK) which binds to C-terminal of
JAM-A, claudin, coxsackievirus and adenovirus receptor (CAR), and occludin by PDZ and SH3
domains[10, 11, 13]. Zonula occluden family and claudin are essential components to form TJ
strands in epithelial cells, while other transmembrane proteins such as occludin help to regulate
TJ strand formation with claudins [11, 13].

Fig 1.2: - Molecular Composition of Tight Junctions. TJ transmembrane proteins (claudins, occludin,
JAM-A), cytosolic plaque proteins (ZO proteins, cingulin, MAGI), they associate with underlying actin
filaments. Adapted from Journal of Investigative Dermatology Volume 127, Issue 11, [2]
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1.2.2 Adherens Junction

Adherens junctions establish cell-cell contacts, regulate the maturation, and maintain the
connecting network[10]. Their proteins perform several functions: they control the formation and
assembly of tight junctions, which seal the paracellular space [14]; they regulate the initiation of
intracellular signaling, membrane receptor, transcription, oncoproteins, and the actin
cytoskeleton; and they stabilize the cell-cell adhesion [10, 15]. The complex of adherens
junctions are composed of the transmembrane proteins cadherin and nectin, which interact with
adjacent cells and with intracellular cytosolic plaque, such as catenin and afadin. Cadherin and
nectin are the core of transmembrane protein of epithelial adherens junction [7, 10, 16].
Together, these proteins regulate the function of adherens junctions [10, 17]. Cadherin is
considered as the large superfamily of calcium-dependent adhesion cell molecules, which
contains multiple copies of extracellular cadherin domain (EC) in the extracellular region. This
EC initiates trans-cadherin interactions between adjacent cells and helps to form the adherens
junctions [10]. Cadherins regulate the cell-cell interaction and cell movement and maintain the
tissue morphogenesis to keep the cell architecture in the adult. Also, they play a significant role
in the development by controlling the cell segregation and formation of the interfaces in distinct
tissue [16, 18, 19]. Increasing invasive phenotype of tumor cells is often correlated to loss or
downregulation of cadherins [18]. E-cadherin is the main transmembrane glycoproteins and one
of Ca2+ dependent adhesion proteins [7, 10]. It is necessary for localization and binding to
catenins which is the part of cytoplasmic proteins that connect the cadherin proteins to actin
cytoskeletons[10]. The cytosolic plaque of the AJ is composed of two armadillo family proteins:
catenin and afadin [7]. The Catenin family involves alpha-catenin, beta-catenin, and p120catenin. These cytosolic plaque proteins regulate local actin assembly by interacting with
intercellular domains of E-cadherin through beta-catenin, which binds directly to alpha catenin
and p120 catenin [14]. The decreasing in the expression of E-cadherin is responsible for
incorrect localization of catenins and other TJ proteins [7, 10].
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Fig 1-3: - Molecular Composition of Adherens Junctions. AJ formed by transmembrane
proteins (cadherins, nectins), cytosolic plaque proteins (catenins, afadin), they associate with
underlying actin filaments. Adapted from Journal of Investigative Dermatology Volume 127, Issue
11, [2]
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1.3 Basic Mechanism of Cell Motility

Cell motility, a complex and highly integrated process, is essential for multiple biological
processes, such as the development of organisms (morphogenesis), neurogenesis, wound healing,
and immune response. Also, it drives the disease progression in cancer metastasis, mental
retardation, arthritis, and atherosclerosis [20, 21]. The mode of the cell migration, which
determines if the cell migrates individually (amoeboid or mesenchymal) or collectively
(migration of cohesive multicellular units) depends on cytoskeleton organization, type of cellmatrix interaction and force generation, and modification of tissue structure imposed by
migrating cells[22]. These two modes of cell motility are known as Collective Cell Migration
and Individual cell migration respectively. The first mode of the cell migration is when the cells
move collectively in a sheet like structure, in the presence of cell-cell junctions; this type of
movement is observed during wound healing in epithelial cells. In contrast, another type of cell
motility is Individual Migration, which happens by separation of cells from each other and move
as a single cell by suppression of intercellular junctions and downregulation of cadherins. In the
case of individual cell migration, there are two main types of the cell morphology, which use the
different mechanism of migration. The first one is elongated, fibroblast-like cells, which undergo
mesenchymal migration. The mesenchymal migration of the elongated morphology cells
depends on integrin-mediated adhesion with substrate and degradation of extra cellular matrix
(ECM) by the matrix-degrading protease which presents in the leading edge of migrating cell.
The second type of the individual cell morphology is rounded cells which undergo amoeboid
migration. Because the cell- substrate adhesion is weak, cells appear as a rounded morphology.
Rounded cells move by amoeboid migration in an integrin-independent adhesion, and they do
not require the ECM degradation. By changing the shape and squeezing themselves through the
gap in ECM, the rounded cells can migrate through it. Thus, the transition from collective
migration to individual migration is called the Epithelial-Mesenchymal transition. The basic cell
motility depends on the reorganization of actin cytoskeleton and consists of four main processes:
protrusion, adhesion, translocation, and retraction. First, cells motility is triggered by external or
internal signaling which interacts with the extracellular receptors and activates the downstream
signaling. The stimulated asymmetric cells and de novo actin filaments polarization occur at the
leading edge. Then, the formation of membrane protrusion such as filopodia and lamellipodia
7

occurs by polarized actin filaments which push against the cell membrane. Secondly, this
protruded membrane attaches to ECM and initiates the novel integrin dependent cell substrate
adhesion formation at the leading edge. The adhesion complexes which recently formed are
stabilized and mature into focal adhesion. Thirdly, translocation of the nucleus and cell body
activated by acto-myosin contractile forces distort the cells into an elongated shape. Finally,
disassembly of focal adhesion and release of cell-substrate rear adhesion allows the tail retraction
[1, 23-27].
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Fig 1-4: - Basic Cycle of Cell Motility. [1] Cancer Science Volume 96, Issue 7, pages 379-386, 29
JUL 2005 DOI:10.1111/j.1349-7006.2005.00062.x

9

1.4 Mechanism of Eukaryotic Translation
Translation of mRNA into protein is one of the multiple levels of regulated gene expression. By
allowing more rapid changes in the cellular concentration of encoded protein, the translation
process maintains the homeostasis in cell physiology and fate. The process of translation is
composed of four main steps: initiation, elongation, termination, and ribosomal recycling.
Multiple different protein factors involved in the translation mechanism interact with mRNA,
transfer RNA(tRNA), and 40S ribosome, where the codon is located, and 60S ribosome. These
interactions promote each stage of the translation process and ensure a mRNA is accurately
translated into protein. Generally, during the initiation stage, the elongation-component 80S
ribosome is formed by recruiting the mRNA to the 40S ribosome and the 60S ribosome. In the
elongation step, the information in each nucleotide triplet (or codon) will be translated into
amino acids by migrating 80S ribosome along the mRNA. These translated amino acids will be
incorporated into a growing polypeptide chain.

During the termination, the newly formed

protein is released by recognizing the stop codon. Lastly, in ribosome recycling, the mRNA and
80S ribosome is released. the 80S ribosome will be separated into its original components: the
40S and 60S subunits, which can then begin the translation cycle again[28, 29].

1.4.1 Eukaryotic Translation Initiation Step
Translation initiation is considered as the rate-limiting step of protein synthesis, and as such, it is
the most highly regulated phase of translation [28-30]. The variance of the initiation rates can be
due to differences in regulatory features of mRNA, such as highly structured 5' un-translated
region (UTR). Another variance could be the regulation of initiation factors by signaling
cascades, such as mitogen-activated protein kinase (MAPK) pathway and mechanistic target of
rapamycin (mTOR). Together, these variances have an effect on availability and activity of
factors which alter the rate of translation [28]. Compared to prokaryotes, the initiation of protein
synthesis in eukaryotes consists of the recruitment of a ribosome initiator tRNA complex to
mRNA initiation codon. Whereas, in prokaryotes, this process occurs by direct interaction of
ribosomal RNA with the mRNA. Eukaryotes have a highly regulated mechanism that relies on
the interaction between the proteins and between protein and the mRNA.
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As a result, the eukaryotic translation initiation has at least eleven different initiation factors
which are required for translation initiation to occur accurately. Together these factors ensure
that the methionyl-initiator tRNA (Met-tRNAiMet), which is placed in the ribosomal P site, is
base paired with the initiator AUG codon of an mRNA. Conceptually, the eukaryotic initiation
process, which leads to formation of 80S ribosome, consists of multiple linked steps which are
mediated by eukaryotic translation initiation factors (eIF). This process can be divided into five
main stages: First, the eIF4F cap-binding complex binds to mRNA; second, a formation of the
43S preinitiation complex (PIC); third, recruitment of mRNA to the ribosome; fourth,
localization of in initiation codon; finally, 80S ribosome will be formed by joining of a 60S
ribosome and 40S ribosome. First, to recruit the target mRNA to the 40S subunit, the mRNA
should be prepared by recognizing and binding to eIF4F complex and PABP. The eIF4F
complex is composed of: three main subunits (eIF4E, eIF4A, eIF4G); and eIF4B as an auxiliary
factor. Together these subunits promote unwinding of secondary structure in 5' UTR by eIF4A.
The 40S subunit is prepared to recruit to mRNA by several eIF factors which bind individually,
or as a multifactor complex. These binding factors include: eIF1, eIF1A, eIF2, eIF3, and eIF5.
The eIF2 binds as a ternary complex which includes eIF2-TC with GTP and the initiator tRNA.
Through direct interaction between eIF4G and eIF3, mRNA is directed to the ribosome.
Following the step of recruitment, 40S subunit begins scanning for initiation codon by traveling
along mRNA in 5' to 3' direction, and sampling codons on the mRNA with initiator tRNA
anticodon. After recognition of initiation codon by base-pairing, GTP in eIF2-TC is hydrolyzed
by eIF5.The eIF2-GDP complex and other initiation factors from 40S are released. By eIF2B,
eIF2 recharges with GTP, and new initiator tRNA is recruited to reform the eIF2-TC. Now, the
initiation factors are free to begin the new round of translation on different mRNA. Until eIF5BGTP recruits and binds 60S subunits, eIF1A interacts with the 40S subunit. In the end, both of
eIF1A and eIF5B-GTP are released following the GTP hydrolysis. Lastly, the newly 80S
ribosome is formed and then enters the elongation cycle, which is followed by the termination
and the recycling steps which results in the release of free 40S and 60S subunits. These released
subunits are prepared for future rounds of translation [28, 29, 31, 32].
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Fig 1.5: - Translation Initiation Mechanism. To form the 43S pre-initiation complex (purple), the 40S
ribosomal subunit (green) interacts with eukaryotic initiation factor 2 (eIF2), GTP and initiator methionyl tRNA. The
eIF4F complex (red), which composed of eIF4E, eIF4G, eIF4A, and eIF4B as an auxiliary factor. Together these
factors bind with 43S, is then recruited to the 5' cap. Poly(A) binding protein (PAB; yellow) bound to 3’ end of mRNA
poly(A) tail in order to facilitate translation initiation by communicating with the 5' end of the mRNA through its
interaction with eIF4G, as a result, the 5' and 3' ends of the mRNA are joined. Then, the 43S complex scans the
mRNA until the AUG codon is recognized. This stimulates eIF5 to hydrolyze GTP, as a result of GTP hydrolysis, the
eIFs dissociate and the 60S subunit joins. In the end, a fully functional ribosome is ready to begin peptide synthesis.
Adapted from Nat Rev Genet. 2003 Aug;4(8):626-37.[4]
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1.4.2 Importance of eIF4G Family in Translation Initiation Mechanism
There are two fundamental features in which the mRNA is selected for translation: 7'-methylguanosine cap binds to 5' end of mRNA; and poly(A) tail is added to 3' end of mRNA. These two
characteristics are protecting mRNA from the degradation and are promoting the translation
initiation. The eukaryotic translation initiation factor 4F(eIF4F) is a heterotrimeric factor, which
is composed of three subunits eIF4E, eIF4G, and eIF4A. These subunits work as cap binding,
molecular scaffold, and DEAD box helicase (ATP-dependent RNA helicase), respectively. Also,
it interacts with 7' methyl-guanosine, and 3' ploy (A) tail directly or indirectly. The fundamental
role of eIF4F is to place in 5' end of mRNA through eIF4E (cap recognition) and to ensure the 5'
end of mRNA will bind to the 40S ribosome. The eIF4G is considered as the largest and core
component of eIF4F and is sufficient for efficient ribosomal attachment to capped mRNA. The
eIF4G contains the binding domains for mRNA, eIF4A, eIF4E, eIF3, poly(A) binding
protein(PABP), and MAPK-interacting kinase(MNKs). By these binding domains, eIF4G works
as molecular scaffolding which regulates and recruits the activation of other eukaryotic
translation initiation factors. It also increases the affinity of the interaction between 5' mRNA cap
structure to eIF4E, and 3' mRNA poly(A) tail to PAPB. The eIF4G promotes the ability of eIF4A
to stimulate the translation by recruiting eIF4A and activating its ATP-dependent RNA helicase
activity. Beside the stabilizing the affinity, eIF4G has two additional essential functions in
mRNA recruitment to the ribosome. This recruitment occurs through interaction between eIF4G
and eIF3. Additionally, eIF4G works as the bridge in 43S PIC and eIF4F-mRNA complex by
interacting with eIF3. The eIF4G interacts with eIF4A (DEAD box helicase) and holds its active
confirmation; this interaction is required to recruit this helicase to mRNA. DEAD box helicase
facilitates the ribosome recruitment and scanning through unwind secondary structure of mRNA
located in 5' UTR in an ATP-dependent manner. It is believed that the eIF4G directly recruits the
43S PIC through the physical interactions with eIF3 and eIF5 in the PIC [28, 32-36].
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Fig 1.6: - Main Role of eIF4G family protein in Translation initiation Stage. eIF4G subunits are
considered the largest component of the eIF4F family; these subunits contain the binding domain for mRNA, PABP,
eIF4A, eIF4E, and eIF. They also stabilize the interaction of eIF4E with cap structure;and PABP with the poly A tail.
Additionally, they directly interact with eIF3, component of 43S Ribosome, and work as bridge between eIF4F –
mRNA complex, and 40S Ribosome. Adapted from Biol Res. 2005;38(2-3):121-46.[3]
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1.5 Why we Study the Role of Translation Initiation in Regulation of the
Epithelial Junctions and Cell Motility?
In this study, the overall goals were to investigate the role of eukaryotic translation initiation
factor (eIF4G) in regulating structure and functions of apical junctions, and motility of intestinal
epithelium and ECM adhesion; and to analyze the roles of eIF4G downregulation in cytokine
induced barrier disruption and inhibited epithelial restitution. There are several reasons for
focusing on translation factor eIF4G on regulating of epithelial junctions and cell motility. First,
epithelial barrier is disrupted during the acute inflammatory phase thus exaggerating
inflammation. Disruption of AJ, TJ, and FA plays a key role in the breakdown of the intestinal
epithelial barrier during the mucosal inflammation [37-39]. For instance, proinflammatory
cytokines relevant to IBD are known to trigger AJ and TJ disassembly and attenuate wound
healing in model intestinal epithelial cell monolayer [40]. Decreased expression of adhesion
proteins has been reported in IBD mucosa and cytokine-treated epithelial cells [41, 42], which
plays a significant role in mediating breakdown of the intestinal epithelial barrier[43]. Second,
mechanisms of cytokines-dependent downregulation of adhesion proteins remain poorly
understood, although evidence suggests that they may involve posttranscriptional events. Protein
translation is an attractive mechanism since it is known to be down-regulated by inflammatory
stimuli in colonic and pancreatic epithelium[6, 44]. Third, little is known regarding the roles of
eIF4G1 and eIF4G2 in regulating the expression of the epithelial adhesion proteins. The eIF4G1
was previously implicated in the control of p120 catenin expression in inflammatory breast
cancer [45]. Furthermore, eIF4G1 was found to be enriched at the leading edge of migrating
fibroblasts [46, 47] and to regulate tumor cell invasion[45, 48]. However, nothing is known
about the roles of eIF4G translational initiator in regulating the integrity and restitution of the
intestinal epithelial barrier under normal conditions or during mucosal inflammation. Based on
this, we hypothesized that the process of translation initiation plays essential roles in regulation
of the intestinal epithelial apical junctions and cell motility in intestinal models.
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1.6 Specific Aims

Aim 1: To investigate the roles of eIF4G-dependent translation of AJ and TJ proteins in the
maintenance and disruption of model intestinal epithelial barrier.

Aim2: To analyze the involvement of translation initiation factors in intestinal epithelial cell
migration and ECM adhesion.

Hypothesis: The process of translation initiation plays essential roles in regulation of the
intestinal epithelial apical junctions and cell motility in intestinal models.
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2. MATERIALS AND METHODS
2.1Cell Culture
Different intestinal epithelial cells that were used were maintained in standard T-flasks. HIEC,
SC-CO15, T84, and HT29 were plated either onto 6 or 24 well plates depending on the
experiment. Cells were allowed to grow in nutrient media until a confluency of 60-80%. The
table provided describes the different components of a nutrient medium which were used for cell
growth.
Cell Type

Basic Medium

Source

Serum Used

MEM-NEAA

HEPES

Pen-step

Cat #

SK-CO15

DMEM

ATCC

FBS 10%

5 ml

7.5 ml

5ml

30-2002

HT 29

DMEM

ATCC

FBS 10%

5 ml

7.5 ml

5ml

30-2002

T84

DMEM/F12

Corning

FBS 20%

----

----

5ml

10092CV

HIEC

OptiMEM 1

Invitrogen

FBS 5%

5ng/ml

0.05 M

----

22600-134

EGF
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2.2 Total Cell Lysates
In order to make lysate, cells were washed three times with HANK's+ on ice. After adding RIPA
buffer, cells were scraped from 6-well dishes by using cell scraper. The RIPA buffer, which is
formed by (20mM Tris, 1% Sodium Deoxycholate, 1% Triton, 50mM NaCl, 20mM EGTA,
2mM EDTA), should contain protease inhibitors (1:100) and phosphatase inhibitors cocktail
(1:200)—both were obtained from Sigma-Aldrich to protect protein's integrity and protein
phosphorylation. Cell were homogenized using Dounce Homogenizers. Then homogenized
samples then were centrifuged for 20 mins at 14,000G, 4°C, and supernatant was diluted in the
equal amount of 2x SDS sample buffer after adding 0.1M Dithiothreitol (DTT). Lastly, samples
were boiled for 6 mins in 100°C, and then stored in -80°C refrigerator. By using BCA protein
assay kit, (ThermoFisherScientific) the protein concentration of total lysate is determined.

2.3 Western Blotting/Immunoblotting
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis (SDS-PAGE) was used to
separate individual proteins. An equal amount of total protein was loaded into each lane (1020ug). After the electrophoretic separation, proteins were transferred by electroblotting technique
onto polyvinylidene difluoride (PVDF) or Nitrocellulose membranes according to the molecular
weight of the proteins. The membrane was then blocked with 5% Non-fat dry milk, diluted into
TBS-T (Tris-Buffered Saline-Tween-20) for an hour. After that, the primary monoclonal or
polyclonal antibodies were added and incubated overnight in a cold room. On the second day,
the membranes treated with primary antibodies were washed three times with TBS-T for 5
minutes each to remove all excess primary antibodies. Then HRP conjugated secondary
antibodies were added to the membrane for an hour at 1:5000 concentration. Then, membranes
were washed with TBS-T three times, followed by three more times washing with TBS for five
minutes each. Finally, membranes were developed by using ECL reagent from GE-Healthcare.
The images were taken on standard x-ray film by using SRX-101A image processor from Konica
Minolta.
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2.4 siRNA–Mediated Protein Knockdown
Cells cultured on 6-well plates were transfected with gene specific siRNA in order to obtain
transient protein knockdown. Eif4G1 and Eif4G2 gene silencing was obtained using specific OnTarget+ siRNA from GE-Lifesciences. The siRNA is specifically designed to reduce off target
effects. As per the mechanism stated by the manufacturer, the sense strand is modified to prevent
interaction with RISC-complex and thus favors anti-sense strand uptake while the anti-sense
strand is modified to destabilize off-target effects and enhance target specificity (Manufacturer’s
manual, GE-Lifesciences). All knockdowns were performed as per manufacturers protocol.
Control siRNA duplex#2 obtained from GE-Lifesciences was used as control in all experiments.

2.5 Generation of Stable Cell Lines with Small Harpin (sh)RNA-Mediated
eIF4G1 and eIF4G2 Knockout
HIEC, and SK-CO15 cell lines with stable shRNA-mediated knockdown of either Eif4G1 or
Eif4G2 were generated using the Sigma-Aldrich MISSION shRNA Lentiviral Transduction
system according to the manufacturer's instructions (Sigma-Aldrich, Saint Louis, MO). All cell
lines were transduced with either Eif4G1 or Eif4G2 shRNA-containing lentiviral particles, and
stable cell lines were selected using puromycin (3 μg/mL for HIEC and 5 μg/mL for other three
lines, respectively). A non-silencing shRNA lentiviral particle (RHS4346), lacking
complementarity to any human gene, was used as a control.

2.6 Antibodies and other reagents
The following commercially-available primary polyclonal (pAb) and monoclonal antibodies
(mAb), which have already been tested in our laboratory, will be used in the proposed study: anti
eIF4G1, eIF4E (Cell Signaling Technology Danvers, MA), Eif4G2 (Bethyl Laboratories,
Montgomery, Tx), anti-occludin, ZO-1, JAM-A, pAbs and anti-E- cadherin, occludin, ZO-1
mAbs (Life Technologies, San Francisco, CA); anti-β-catenin (BD Biosciences, San Diego CA.)
Anti-puromycin mAb (Kerafast Boston, MA) Alexa-488-conjugated G-actin, rhodaminephalloidin, as well as Alexa-488 or Alexa-568 dye-conjugated donkey anti-rabbit and goat anti-
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mouse secondary antibodies will be obtained from Invitrogen (Eugene, OR); horseradish
peroxidase-conjugated goat anti-rabbit and anti-mouse secondary antibodies will be obtained
from Jackson Immunoresearch Laboratories (West Grove, PA). All other reagents will be
purchased from Sigma-Aldrich.

2.7 Immunofluorescence Labelling and Confocal Microscopy
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell
lines with shRNA mediated knockdown, were grown in a collagen-coated coverslip in 24 well
dishes. Confluent cells on 4th-day post-transfection were fixed in 100% Methanol for 20 minutes
at -20°C. After fixation, the cells were blocked by using Bovine Serum Albumin (BSA) in the
dark for one hour. Combination primary antibodies, which were prepared by diluting them in
BSA (1:300), were added to cells for an hour. Then, the cells were washed three times with BSA
for five minutes each. Next appropriate secondary Antibodies diluted in BSA at 1:1000 were
added. Next cells were washed three times with BSA for five minutes each. Lastly, coverslips
were placed on the glass slide using Prolong Gold Antifade reagent (Applied Biosystems).
Stained cells were examined by using a Zeiss LSM 700 Laser scanning microscope. The images
were analyzed by using Zen Lite software (Carl Zeiss Microscopy).

2.8 Puromycin Incorporation Assay
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell
lines with shRNA mediated knockdown, were grown in a collagen-coated coverslip in 24 well
plates. On the day of the experiment a using 200 ul pipette a scratch wound was created. Cell
were allowed to move and 3h post-wounding samples were treated with DMEM containing 5 μM
puromycin for 30 min prior to cell fixation. Cells were washed two times with HANK’S and
proceeded to staining with anti-pyrumycin antibody to detect the newly translated proteins.

2.9 Transepithelial Electrical Resistance (TEER)
Transepithelial electrical resistance (TEER) of cultured epithelial cell monolayers was measured
using an EVOMX voltohmmeter (World Precision Instruments, Sarasota, FL). The resistance of
cell-free collagen-coated filters was subtracted from each experimental point.
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2.10 Wound Healing Assay/ Scratch Assay
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell
lines with shRNA mediated knockdown, were grown on 6-well plates. On the 4th day posttransfection, a horizontal thin scratch wound was performed in the confluent area of the cells
monolayer by using a 200μl pipette tip. After making the scratch, the previous medium was
removed and replaced by new one. Images of the scratch were capture in 0h, 24h, and 48h
depending on the cell types. After that, the cell-free area was measured by using Image J
software.

2.11 Spreading Assay
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell
lines with shRNA mediated knockdown, were grown on 6-well plates. On the 4th day posttransfection, cells were detached from plates by using TrypLE Express and counted with the
hemocytometer after they were re-suspended in standard medium. First, 24 well plates were
coated with 200μl of type-1 collagen and incubated overnight in order to dry. Then, 107 cells
were seeded onto the plates. The cells were incubated for one hour to allow the cells to attach
and spread over collagen type 1 at 37°C. Then, the cells were fixed with 70% ethanol for 10
minutes and stained by using DIFF stain kit. Lastly, the images of spread cells were taken by
light microscope under 20x power and the area of spreading was measured by Image J software.

2.12 ECM Adhesion Assay
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell
lines with shRNA mediated knockdown, were grown on 6-well plates. On the 4th day posttransfection, cells were detached from plates by using TrypLE Express and counted with the
hemocytometer after they were re-suspended in standard medium. Then, 107 cells were seeded
onto 24 well plates which coated with type-1 collagen overnight. The cells then incubated for
one hour at 37 °C to allow the attachment of the cells to ECM. After incubation, the Nonattached cells were removed by extensive washing up and down with 1ml of cell culture
medium. Then the cells were fixed with -20°C methanol for 10 minutes.
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Then the cells were stained by using a DIFF stain kit. The staining-adherent cells were examined
by using light microscope under power 10x, and the number of adherent cells was manually
counted.

2.13 Transfilter Migration Assay
In order to perform Transfilter migration assay24 well plates each with Transwells® with 8.0μm
pore size inserted in was used (Corning Incorporated, Costar®). The 50ul of the collagen type 1
was coated on the membranes and incubated overnight. Then, on the 4th day post-transfection,
cells were detached from 6 well plates by using TrypLE Express and counted with the
hemocytometer after they were re-suspended in 0.1 % FBS medium and added to the upper
chamber of the . In contrast, the complete standard medium 10% FBS was added to the lower
chamber of the Transwells which were previously prepared on the night before. The cells were
incubated for 24h at 37°C to allow them to migrate overnight. After 24h, cells were fixed by
using Methyl Alcohol from DIFF Stain Kit for 5 minutes. By using cotton swabs, the nonmigrating cells were removed from the top of the filtered membrane. The cells in the bottom of
the filtered membrane were stained with DAPI (nuclear stain), and the filters were mounted on
microscope slides. By using the fluorescence microscope, the migrating cells were examined and
counted manually.

2.14 Cytokines and Pharmacological Inhibitors Treatment
For cytokine treatment, IFNγ (50 ng/ml) and TNFα (10 ng/ml) were added to both the cells in 6well plates in order to harvest the cell lysate for immunoblotting, and in apical and the
basolateral Transwell chambers of 24 well plates for 24h and 48 h to perform immunofluorescent
staining. In the case of Pharmacological inhibitors treatment, which involves Ribavirin (20 μM)
and 4EGI-1 (25μM), were added to 60-80% confluent cell in 6-well dishes and make wound
after 2h post-treatment incubation. The images were obtained in 0h, 12h, and 24h post-wounded
depending on the types of the cells. The appropriate dimethyl sulfoxide (DMSO) was added to
control samples.
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2.15 Quantitative Real-Time RT-PCR
Total RNA was isolated using an RNeasy mini kit (QIAGEN, Valencia CA), followed by DNase
treatment to remove genomic DNA. Total RNA (1 µg) was reverse transcribed using an iScript
cDNA synthesis kit (Bio-Rad Laboratories). Quantitative real-time RT-PCR was performed
using iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories) and a 7900HT Fast Realtime PCR System (Applied Biosystems; Foster City, CA).
The following primers were used for Claudin 4: forward: 5’-CCCCAGTGACAAAAACCC-3’;
and reverse: 5’-ACGGACTTAAACGTTCGCA-3’.
β-Catenin:

forward:

5’-

and

ACAAACTGTTTTGAAAATCCA-3’;

reverse:

5’-

CGAGTCATTGCATACTGTCC-3’.
E-cadherin

forward:

5’-TTACTGCCCCCAGAGGAT-3’;

and

reverse:

5’-

TGGAACGTCGTTACAGTG-3’.
Expression levels were normalized to the house-keeping gene GAPDH (forward: 5’reverse:

CATGTTTGTGATGGGTGTGAACCA-3’);

(5’-

AGTGATGGCATGGACTGTGGTCAT-3’).

The threshold cycle number (Ct) for specific genes of interest and the housekeeping gene was
determined based on the amplification curve representing a plot of the fluorescent signal
intensity versus the cycle number. The relative expression of each gene was calculated with a
comparative Ct method that is based on the inverse proportionality between Ct and the initial
template concentration (2-ΔΔCt), as previously described [49]. This method is based on the twostep calculation of ΔCt = Ct target gene – Ct GAPDH and ΔΔCt = ΔCte-ΔCtc where indexe
refers to the sample from any control or eIF4G1 and eIF4G2 siRNA or corresponding miRNA
treated cells, and index c refers to a sample from a control siRNA or control miRNA-treated cells
assigned as an internal control.
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3. RESULTS- PART I

3.1 Proinflammatory Cytokines Induce Disassembly of Intestinal Epithelial
Tight and Adherens Junctions.
In order to investigate the effects of proinflammatory cytokines on the integrity of intestinal
epithelial junctions, the polarized HT-29 cF8 (clone F8) cell monolayer was exposed for 48 h to
either IFNγ alone (50 ng/ml) or in combination with TNFα (10 ng/ml). Integrity of AJ was
evaluated by immunolabeling of HT-29 cells with β-catenin, whereas TJ integrity was examined
by immunolabeling of ZO-1. Confocal microscopy shows that IFNγ induces focal disruption of
characteristic AJs, and TJs labeling (arrowheads), indicating junctional disassembly. TNFα
dramatically exaggerates this effect. Together, these observations indicate that proinflammatory
cytokines triggers disassembly of AJ and TJ in intestinal epithelial cells monolayer (Fig. 3.1).

Figure 3.1. Proinflammatory cytokines induce disassembly of intestinal epithelial tight
junctions and adherens junctions Confluent HT29 cell monolayers were treated for 48 h
with either vehicle, IFNγ or a combination of IFNγ and TNFα. Localization of AJ and TJ
proteins, β-cadherin and ZO-1, was determined by fluorescence labeling and confocal
microscopy. IFNγ induces disappearance of AJ and TJ proteins from the areas of cell-cell
contact (arrowheads), while TNFα potentiates IFNγ-driven junctional disassembly.
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3.2 Proinflammatory Cytokines Decrease the Expression of TJs and AJs
without Affecting their mRNA Levels.
Given microscopy data revealing disassembly of AJ and TJ treated with cytokines in Figure 3.1,
the effect of proinflammatory cytokines on the expression of different AJ and TJ proteins was
next investigated. Human HT29 and T84 colonic epithelial cells monolayer were treated with
either vehicle (PBS) IFNγ alone (50 ng/ml), and in combination with TNFα (10 ng/ml). Total
cell lysate were prepared at 24 h and 48 h of cytokine exposure. Immunoblotting revealed the
significant downregulation of AJ proteins (E-cadherin and p120 catenin) and the TJ protein
(occludin) in cytokine-treated cells (Fig. 3.2A). By contrast, quantitative RT-PCR analysis did
not reveal changes in mRNA expression of selected junctional proteins in cytokine-treated
epithelial cells (Fig. 3.2B). These results indicate that proinflammatory cytokines disrupt the
integrity of the intestinal epithelial barrier via expressional down-regulation of different AJ and
TJ proteins. Such downregulation can occur without inhibition of mRNA transcription.

Figure 3.2. Proinflammatory cytokines decrease the expression of intestinal epithelial tight junctions
and adherens junctions without affecting their mRNA levels
(A) Western blot analysis reveals that cytokines decrease expression of different AJ and TJ proteins in HT
29 and T84 human intestinal epithelial cell lines.
(B) Real time RT-PCR analysis of mRNA levels of selected junctional proteins in IFNγ and TNFα treated
HT 29 cells.
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3.3 Cytokines Decrease Expression of Different Translation Initiation Factors
in Intestinal Epithelial Cell Lines
Our data suggest that proinflammatory cytokines disrupt the integrity of epithelial junctions by
decreasing expression of different AJ and TJ proteins at post-transcriptional level. We
rationalized that this mechanism may involve inhibition of protein translation and especially its
rate-limiting step: translation initiation. Therefore, we next sought to investigate the effects of
proinflammatory cytokines on expression of major translation initiation factors. To do that, again
we compared expression of eIF4G1 and eIF4G2 isoforms in control and IFNγ/TNFα of treated
both HT-29 and T84 cells, along with expression of other components of the eIF4F capdependent translation initiation complex (eIF4E). Cells were harvested for cell lysates on the 24h
and 48h of the cytokine treatment. The immunoblotting analysis shows that exposure of T84 cell
monolayers to either IFNγ or IFNγ plus TNFα resulted in dramatic downregulation of eIF4G1
and eIF4G2 protein expression (Fig. 3.3A). Likewise, this cytokine combination reduced the
expression of both eIF4G isoforms in HT-29 cells (Fig. 3.3B). The same inhibitory effects were
evident for eIF4E expression. This data suggests that proinflammatory cytokines deplete major
components of protein translation initiation machinery in intestinal epithelial cells in vitro.
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Figure 3.3. Cytokines decrease expression of different translation initiation factors in
intestinal epithelial cell lines in vitro.
Representative immunoblots of HT 29 cells (A) and T84 (B) show that exposure of cells to
either IFNγ or IFNγ plus TNFα markedly decreases levels of translation initiation factors
eIF4G1, eIF4G2 and eIF4E.
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3.4 Decreased Expression eIF4G2 in Intestinal Mucosa of IBD Patients
Given our results that proinflammatory cytokines decrease expression of different translation
initiation factors in vitro, we sought to examine if similar events may also happened during
intestinal inflammation in vivo. In order to do that we performed dual immunofluorescence
labeling of eIF4G2 (green) and β-catenin (red) in affected colonic sections of patients with a B2
Montreal classification of Crohn’s disease, as well as normal colonic mucosa of patients
undergoing intestinal surgery. The banked tissue sections were provided by Dr. John Kuemmerle
from the GI Division at VCU Medical Center. As shown in figure 3.4, in normal colonic mucosa,
eIF4G2 was abundantly expressed in epithelial cells (Fig. 3.4, arrows). In contrast, labeling
intensity of this translational initiator was decreased in IBD mucosa (Fig. 3.4 arrowheads).
Overall these data are consistent with in vitro experiment result on figure 3.3, mucosal
inflammation decreases levels of eIF4G1 and eIF4G2 in intestinal epithelium in vitro and in vivo
(Fig 3.4).

Figure 3.4. Decreased expression of a translation initiation factor in inflamed human
intestinal mucosa in vivo.
Immunofluorescence images show diffuse eIF4G2 staining in normal colonic epithelia and marked
reduction of eIF4G2 labelling in colonic mucosa of CD patient.
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3.5 Knockdown of eIF4G1 and eIF4G2 Decreases Expression of Different AJ
and TJ Proteins in Human Colonic Epithelial Cell Monolayers
In order to investigate the role of eIF4G subunits on the integrity of epithelial junctions, the
expression of two major eIF4G isoforms in epithelial cells was downregulated by using RNA
interference (RNAi). To do that, eIF4G1 and eIF4G2 specific siRNA individual duplexes (D1D4) were used. SK-CO15 human colonic epithelial cells were transfected with the control,
eIF4G1, and eIF4G2 siRNA. The Expression of different AJ and TJ proteins was examined on
day 4 post-transfection. Figure 3.3 shows that loss of these translation initiation factors decreases
the expression of several junctional proteins. Interestingly, eIF4G1 appears to regulate the
expression of both AJ and TJ proteins (Fig. 3.5A), whereas eIF4G2 was found to be a more
selective regulator of TJ constituents (Fig. 3.5B).

Figure 3.5. Knockdown of eIF4G1 and eIF4G2 decreases expression of different AJ and TJ proteins.
SK-CO15 cells were transfected with either control, eIF4G1 or eIF4G2 siRNAs. Four days after the
knockdown effects of eIF4G isoform knockdown on expression of different AJ and TJ proteins was
determined by immunoblotting analysis.
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3.6 siRNA-Mediated Depletion of eIF4G1 Prevents Formation of the
Paracellular Barrier
Since previous experiments indicate that, depletion of eIF4G1 and eIF4G2 downregulates the
expression of different AJ and TJ proteins, we next sought to investigate the roles of these
translation initiation factors on paracellular barrier formation and assembly of epithelial
junctions. The initial series of experiments involved transient siRNA-mediated knockdown of
eIF4G1. Paracellualr permeability was examined by measuring Transepithelial Electrical
Resistance (TEER) from 2nd day through 4th day post transfection. We observed that loss of
eIF4G1 in SK-CO15 cells significantly attenuate development of decreased TEER as compared
to control siRNA-transfected cells (Fig. 3.6A). After measuring TEER, the cell monolayers were
fixed and immunolabelled for β-catenin, occludin, claudin 4 (red) to visualize both AJ and TJ,
and eIF4G1(Green) to visualize areas of its efficient knockdown. As a result, Figure 3.6B shows
that depletion of eIF4G1 disrupted β-catenin and claudin-4 localization at apical junctions
without having effect on occludin localization. Overall, these results suggest that eIF4G
translation initiation factors play an essential role in the assembly of apical junctions and
regulation of the intestinal epithelial barrier.

Subsequent experiments were aimed at establishing SK-CO15 cell lines with stable shRNAmediated knockdown of either eIF4G1 or eIF4G2. These cell lines were created using proteinspecific shRNA plasmids cloned into a lentiviral vector. Ready to use lentiviral particles were
obtained from Sigma, SK-CO15 cells were infected with these lentiviral particles and stable cell
lines were generated after puromycin selection. Control, eIF4G1 or eIF4G2 depleted SK-CO15
cells were plated on Transwell membrane filters, and TEER was measured on days 1-3 after the
cells reached confluency. The results of this TEER measurement indicate that loss of either
Eif4G1 or Eif4G2 impaired the development of the paracellular barrier (fig. 3.7).
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Figure 3.6. siRNA-mediated depletion of eIF4G1 prevents formation of the paracellular
barrier and attenuates AJ and TJ assembly.
(A) TEER measurements demonstrate that eIF4G1-depleted SK-CO15 cell monolayers fail to
develop the paracellular barrier. Data are presented as mean ± SE, n=3 *p<0.01.
(B) Immunofluorescence labeling shows formation of normal β-catenin-based AJs and occludin
and claudin 4-based TJs in control SK-CO15 cell monolayers on day 4 post-transfection. By
contrast, eIF4G1-depleted cells have significant intracellular accumulation of β-catenin
(arrowheads) and fragmented claudin4-based TJ strands (arrowheads).
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Figure 3.7. shRNA-mediated depletion of eIF4G1 and eIF4G2 prevents the formation of the
paracellular barrier in SK-CO15 cell lines. Control, eIF4G1 or eIF4G2-depleted SK-CO15 cells
were plated on membrane filters and TEER was measured at indicated time points after cell reached
confluency. Data are presented as mean ± SE, n=3 *p<0.01.
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4. RESULTS- PART II

4.1 Newly Synthesized Puromycin-Positive Nascent Polypeptide Chains are
Present at the Leading Edge of Migrating Cells.
Results of prior studies suggest that protein translation machinery could be localized at the
leading edge of migrating individual cells such as fibroblasts [47, 50]. Based on these
observations we started our study of the roles translation initiation in migration of intestinal
epithelial cells by visualizing de novo protein translation in migrating cell monolayers. In order
to do that, we used Puromycin Incorporation Assay. This assay is based on structural similarity
between puromycin amino acyl-transfer RNA (aminoacyl-tRNA), which allows for puromycin
incorporation into a newly synthesized elongated polypeptide chain by forming a peptide
bond[51]. Confluent HT-29 cell monolayers were wounded and allowed to migrate into the
wound for 3 h. Then, 1µg/ml puromycin was added for additional 5 min. Thereafter, cells were
fixed and stained with anti-puromycin mAb to assess localization of de novo protein translation
in migrating cell monolayer [46]. Such pulse labeling with puromycin of the active sites of
protein synthesis revealed that translation occurs exclusively at the leading edge of migrating
epithelial sheet (Fig. 4.1).
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Figure 4.1. Newly synthesized puromycin-positive nascent polypeptide chains are present at
the leading edge of migrating epithelial cells. Wounded HT 29 cell monolayers were, incubated for
5 minutes with 1µg/ml puromycin, with subsequent fixation with anti-puromycin mAb (red). The
cells were counterstained for filamentous actin (green).
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4.2 Cell Migration Alters Intracellular Localization of eIF4G2 in Intestinal
Epithelial Cells
Because the results of previous experiments presented in figure 4.1 indicate that the nascent
polypeptide chains are present at the leading edge of migrating cells, we next examined
localization of eIF4G2 in stationary and migrating human intestinal epithelial cells. In this
experiment, we used immortalized non-transformed HIEC cells, which are poorly differentiated
stem cell like intestinal epithelial cells with high expression of eIF4G2. Immunoblotting analysis
of eIF4G2 HIEC cells with a rabbit polyclonal antibody reveal a single bang of correct size,
which disappeared after eIF4G2 knockdown, which indicates specificity of this antibody (data
not shown). Surprisingly, we found that eIF4G2 was localized at nucleus in stationary cells
intestinal epithelial cells (figure 4.2A). However, wound healing resulted to dramatic
recolocalization of this translation initiation factor that become abundant in the cytosol and
leading edge of the migrating cells (Figure 4.2B). Together our immunolabeling experiments
suggest that motility of intestinal epithelial cells could be driven by local translation of essential
regulators of cell motility at the leading edge of migrating cells.

35

Figure 4.2. Confocal Images Showing Localization of eIF4G2 in Stationary (A) and
Moving Cells (B). The confluent non-transformed HIEC cells were wounded by10μM
pipette. Then cells were fixed and dual labelled for eIF4G2 (green) and F-actin (red).
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4.3Pharmacological Inhibition of the eIF4E-Dependent Protein Translation
Attenuated Motility of Intestinal Epithelial Cell Monolayers
The next series of experiments were designed to demonstrate causal roles of eIF4G-dependent
translation initiation in the regulation of intestinal epithelial cell motility. Since eIF4G proteins
regulate translation by interacting with eIF4E cap-dependent translation initiation factor, we used
two pharmacological inhibitors that target different aspects eIF4E-dependent translation. One
inhibitor is Ribavirin, an anti-viral drug, which is known to decreases the affinity of eIF4E to m7
G cap of mRNA[52]. For the other inhibitor is 4EGI-1, a small molecule which inhibits the
binding between eIF4G proteins and eIF4E resulting in inhibiting the cap-dependent translation
initiation [53]. The experiments with pharmacological inhibition of protein translation initiation
were conducted in both poorly differentiated HIEC and well-differentiated T84 intestinal
epithelial cells. Confluent HIEC and T84 cell monolayers were wounded and then allowed to
migrate to close the wound in the presence of either vehicle, Ribavirin, or 4EGI-1. Images were
obtained for HIEC cells at 0 h when the wound initiated and 12 h of wound closure. For T84
cells, the images were taken at 0 h when the wound initiated and 24 h post wounding. As shown
in Figures 4.3 and 4.4, a significant attenuation of wound closure by two inhibitors of translation
initiation was observed in both cell lines. These results suggest that translation initiation is
essential for collective migration of either stem cell-like or well-differentiated intestinal
epithelial cells.
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Figure 4.3. Ribavirin and 4EGI-1 attenuate the collective cell migration of HIEC cells. Effects
of Ribavirin and 4EGI-1 inhibitors on the collective cell migration was determined by wound healing
assay. HIEC cells were wounded and allowed to migrate in the presence of either vehicle, Ribavirin
(20 μM), or 4EGI-1 (25 μM). The images were obtained in 0h and 12h post-wounding.
Representative images of wounded monolayers (A) and quantification analysis of wound closure (B)
are shown. Data are presented as mean ± SE, n=3 *p < 0.01.

38

A

B

Figure 4.4. Ribavirin and 4EGI-1 attenuate the collective cell migration in T84 cells. Effects of
Ribavirin and 4EGI-1 inhibitors on the collective cell migration was determined by wound healing
assay. Confluent T84 cells were wounded and allowed to migrate in the presence of either vehicle,
Ribavirin (20 μM), or 4EGI-1 (25 μM). The images were obtained in 0 h and 24 h post-wounding. The
images were obtained in 0h and 12h post-wounded. Representative images of wounded monolayers
(A) and quantification analysis of wound closure (B) are shown. Data are presented as mean ± SE, n=3
*p < 0.01.
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4.4 Both eIF4G1 and eIF4G2 are Essential Regulators of Collective Migration
of Intestinal Epithelial Cells
Since our experiments with pharmacological inhibition of protein translation initiation
demonstrated essential role of this process in the regulation of intestinal epithelial cell migration,
we next sought to investigate if eIF4G1 and eIF4G2 play unique or redundant roles in cell
motility. To address this question, we transiently and specifically down-regulated expression of
each translation initiation protein in either HIEC or T84 intestinal epithelial cells and determined
the effects of such knockdown on epithelial wound healing. Interestingly, loss of eIF4G2
expression significantly attenuated collective migration of HIEC cells, whereas eIF4G1
knockdown was ineffective (figure 4.5). By contrast depletion of either eIF4G1 or eIF4G2
attenuated wound heling in T84 cell monolayers with similar efficiency (figure 4.6). These
results highlight eIF4G2 as a universal regulator of intestinal epithelial cell motility
independently of cell differentiation state. On the other hand, eIF4G1 appears to be dispensable
for collective migration of stem like cells, but was required for migration of well-differentiated
epithelial cells.
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Figure 4.5. Depletion of eIF4G2 inhibits epithelial cell migration. Control, eIF4G1 and eIF4G2–
depleted HIEC cell monolayers were mechanically wounded on day 4 post-transfection. To examine
the rate of cell motility, the cell-free area was measured at 0 and 10 h after wounding. Representative
images of wounded monolayers (A) and quantification analysis of wound closure (B) are shown.
Data are presented as mean ± SE, n=3 *p < 0.01.
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Figure 4.6. Depletion of eIF4G1 and eIF4G2 inhibits epithelial cell migration. Control, eIF4G1
and eIF4G2–depleted T84 cell monolayers were mechanically wounded on day 4 posttransfection.
To examine the rate of cell motility, the cell-free area was measured at 0 and 24h after wounding.
Representative images of wounded monolayers (A) and quantification analysis of wound closure (B)
are shown. Data are presented as mean ± SE, n=3 *p < 0.01.

42

4.5 Depletion of eIF4G1 and eIF4G2 Decreases Individual Cell Migration of
HIEC Cells.
Wound healing assays captures just a single mode of collective cell migration. Therefore, we
sought to expand our study to examine the roles of eIF4G1 and eIF4G2 in regulation of
individual cell motility that could be essential for tumor cell dissemination. Individual motility of
control, eIF4G1, or eIF4G2-depleted HIEC cells was examined by monitoring transfilter cell
migration in the Boyden chamber. We found that depletion of either eIF4G1, or eIF4G2
significantly decreased individual migration of HIEC cells with eIF4G1 depletion being more
potent inhibitor of cell motility. Overall, these experiments suggest that eIF4G1 and eIF4G2 play
non-redundant roles in regulating collective and individual migration of intestinal epithelial cells
in vitro. eIF4G2 appears to be universal regulator of cell motility, whereas the involvement of
eIF4G1 is more limited and depends on the experimental conditions(Fig.4.7).
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Figure 4.7. Knockdown of eIF4G1 and eIF4G2 decrease transfilter migration of HIEC cells.
HIEC Cells were transiently transfected with Control, eIF4G1, eIF4G2 siRNA. As described in
materials and methods, Control, eIF4G1, and eIF4G2 depleted HIEC cells were subjected to
Transfilter migration assay. The bar graph represents the number of cells migrated between control,
eIF4G1, and eIF4G2 depleted HIEC cells. Data presented as mean ± SE, n=3 *p < 0.01, #p < 0.05.
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4.6 eIF4G1 and eIF4G2 do not Regulate Cell- ECM Adhesion, while eIF4G2 is
Essential Regulator of Cell Spreading
Since cell migration is a multistep process we next sought to investigate which steps could be
regulated by eIF4G1 and eIF4G2 in motile intestinal epithelial cells. Cell adhesion to the ECM
and cell spreading over ECM are initial steps of cell migration and are considered as the rate
limiting steps, we investigated how these events could be affected by eIF4G1 and eIF4G2
knockdown in HIEC cells. Figure 4.8 shows that transient depletion of eIF4G1 and eIF4G2 had
not effect on the adhesion of HIEC cells to collagen I matrix. Furthermore, loss of o eIF4G1 did
not affect cell spreading on collagen I (Fig. 4.9). By contrast depleted on eIF4G2 resulted in a
dramatic increased the surface area of attached HIEC cells, thereby indicating the increased cell
spreading (figure 4.9).
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Figure 4.8. Knockdown of eIF4G1/eIF4G2 does not effect on epithelial cell-matrix adhesion.
HIEC Cells were transiently transfected with Control, eIF4G1, eIF4G2 siRNA. The adhesion assay
was performed using Control, eIF4G1, eIF4G2 knockdown cells on the 4th day post transfection.
Note that there is no difference in the number of the cells adhered to the matrix between eIF4G1and
eIF4G2 cells as compared to control cells. Fig.14A shows the images for stained Control, eIF4G1,
eIF4G2 knockdown cells. Fig.14B shows the quantification of the adhesion assay.

46

A

B

Figure 4.9. eIF4G1, eIF4G2 knockdown accelerate cell spreading in HIEC cells. HIEC cells
were transiently transfected with Control, eIF4G1, and eIF4G2 siRNA. The cell spreading assay was
performed on the 4th day post transfection. 107 cells were loaded onto 24-well plates which were
coated with Collagen type-1 overnight and were allowed to settle for one hour. Images were obtained
by using high power microscope. Note that the eIF4G2 knockdown cells spread faster as compared
to the control cells. Data presented as mean ± SE, n=3 *p < 0.01.
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4.7 Loss of eIF4G1 Triggered Loss of Myoepithelial Phenotype in Stem CellLike Intestinal Epithelial Cells
While working with HIEC cells depleted of either eIF4G1, or eIF4G2 we made a serendipitous
observation that eIF4G1 deficiency caused dramatic alterations in cell shape. Indeed, control
HIEC cells displayed an elongated spindle-like shape that is characteristic for either
mesenchymal, or myoepithelial cells. By contrast, eIF4G1-depleted HIEC cells become
orthogonal-shaped, which is more characteristic of epithelial cells (figure 4.10A). No significant
alterations in cell shape was observed after eIF4G2 knockdown (figure 4.10A). In order to gain
insights into molecular mechanisms that underline such dramatic cell shape changes, we
performed immunoblotting analysis of expression of mesenchymal (vimentin) and myoepithelial
(α-SMA, L-Caldesmon, and Sm 22) markers in these cells. Interestingly, eIF4G1 depletion did
not change vimentin expression, but decreased the levels of all tested myoepithelial markers
(figure 4.10B). Expectedly, no changes in expression of either mesenchymal or myoepithelial
markers was observed in eIF4G2-depleted HIEC cells. Interestingly, loss of myoepithelial
markers caused by eIF4G1 depletion was not accompanied by the induction of classical Ecadherin (data not shown), which suggests that we did not observe a myoepithelial-to-epithelial
transformation. Instead, loss of eIF4G1 is likely to transform HIEC in some yet to be
characterized poorly-differentiated state. Importantly, all tested myoepithelial markers are
important organizers and regulators of the intracellular actin cytoskeleton. Loss of these proteins
is likely to disrupt normal organization of actin filament thereby contributing to inhibited
motility of eIF4G1-depleted HIEC cells.
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Figure 4.10. Altered cell shape and decreased expression of myoepithelial markers in eIF4G1deficient HIEC cells. (A) The effect of eIF4G1, or eIF4G2 depletion on HIEC cell shape was
examined by using bright-field microscopy. B) Immunoblotting analysis of expression of
mesenchymal and myoepithelial markers in total lysates of control, eIF4G1, or eIF4G2-depleted
HIEC cells.

49

5. DISCUSSIONS

5.1 Proinflammatory cytokines and their effect on translation of AJs and TJs
proteins in intestinal epithelial cell monolayers; and on the protein
translation initiation machinery.
A number of previous studies[41, 54], and our initial interesting finding results (Fig.3.1, 3.2A),
strongly suggest that proinflammatory cytokines disrupt the integrity of the intestinal epithelial
barrier via expressional down-regulation of different AJ and TJ proteins. Such downregulation
can occur without inhibition of mRNA transcription or enhanced degradation of junctional
proteins[55-57] and is shown in Figure 3.2B. These findings are consistent with conclusion of
our previous study on pancreatic epithelial cells (HPAF-II) [6], which demonstrated that the
treated HPAF-II cells with IFNγ alone or the combination of IFNγ plus TNFα weakens the
pancreatic epithelial barrier by inducing the disassembly of pancreatic AJ and TJ proteins. Also,
the expression of different AJs and TJs were downregulated by exposure to proinflammatory
cytokines.
Then, we determined the effects of proinflammatory cytokines on the protein translation
initiation machinery. We examined if cytokine-induced expressional downregulation of different
AJs and TJs proteins is accompanied by inhibition of eIF4G-dependent translation initiation in
the intestinal epithelium. Expression of eIF4G1 and eIF4G2 isoforms was compared in control
and IFNγ alone or combination with TNFα, in treated HT-29 and T84 cells, along with
expression of other components of the eIF4F cap-dependent translation initiation complex
(eIF4E). We observed that expression of intestinal epithelial eIF4G1, eIF4G2 and eIF4E is
downregulated by proinflammatory in vitro. Likewise, we demonstrated the relevance of these
findings to human IBD, and we performed dual immunolabeling of eIF4G2 and β-catenin in
affected colonic sections of patients with a B2 Montreal classification of Crohn’s disease. We
also used normal colonic section from patients undergoing intestinal surgery. We found that, in
normal colonic mucosa, eIF4G2 was abundantly expressed in epithelial cells (Figure 3.4,
arrows). In contrast, labeling intensity of this translational initiator was decreased in IBD mucosa
(Figure 3.4 arrowheads). This finding is consistent with in vitro result in Figure 3.3, [58, 59] and
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suggests that mucosal inflammation decreases levels of eIF4G1 and eIF4G2 in intestinal
epithelium in vivo.
Our results (figures 3.3 and 3.4) are consistent with a previous study that demonstrated eIF4G1
control of p120 catenin expression in IBC (inflammatory breast cancer). Overexpression of
eIF4GI was observed in IBC, which is responsible for the pathological features of IBC such as,
overexpression of E-cadherin, strong cancer cell interaction, tumor emboli formation, and IBC
cell invasion. However, the downregulation of eIF4GI will block formation of tumor cell emboli
by impairing cap-dependent mRNA translation of p120 [45].
In addition, there are many evidences indicating that the overexpression of eIF4GI has an
oncogenic role and promotes the process of tumorigenesis. For example, overexpression of
eIF4GI has been seen in different types of cancers: lung cancer, hypopharyngeal cancer,
nasopharyngeal carcinoma (NPC), and IBC [45, 48, 60, 61].
Since our finding shows inhibition of eIF4G1 and eIF4G2 protein expression in cytokine- treated
epithelial cells, there are two possible mechanisms of inhibition which we will explore in the
future. The first mechanism comprises transcriptional downregulation of eIF4G isoforms,
whereas another mechanism involves proteolytic degradation of these translational initiators.
These two possibilities are consistent with previous studies which demonstrated caspase and
calpain-dependent cleavage of eIF4G1 and eIF4G2 under different experimental conditions [6264].

5.2 eIF4G isoforms and their roles in regulating the structure and
permeability of model intestinal epithelial barriers.
Given our previous published paper, [6] it has been shown that the proinflammatory cytokines
induce permeability of human pancreatic epithelial monolayers, and that there is a decrease of
the integrity of epithelial barrier which is revealed by decrease the TEER measurements. We
want to investigate if the depletion of eIF4G isoforms, which correlates with downregulation in
the expression of different AJs and TJs, has an effect on the integrity of intestinal epithelial
barrier and permeability. The results of this finding strongly suggest that the eIF4G isoforms
(eIF4G1 and eIF4G2) have the important role in: regulation of the integrity and assembly of
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epithelial AJs and TJs; and permeability of model intestinal epithelial barriers. This result is
supported by two lines of evidence. The first is a significant decrease the expression of AJ and
TJ proteins in depletion of eIF4G isoforms in intestinal epithelial cell monolayers (Figures 3.5A
and 3.5B). The second evidence is that the eIF4G isoforms depletion prevents the formation of
the paracellular barrier and attenuates AJ and TJ assembly. Also, eIF4G isoforms are known to
control the translation of not only AJ and TJ components, but other different proteins [29, 65,
66]. our experiments were designed to minimize the possible effects of altered cell motility and
proliferation on junctional regulation. We have used two different approaches. One approach was
involved in transient knockdown of eIF4G1 or eIF4G2 in SK-CO15 cells and HT 29 cells [67,
68]. The second approach has involved the creation of stable inducible knockdown of eIF4G
isoforms in SK-CO15 cells using a lentiviral transduction system [69]. As described in our
recent lab papers [6, 70], paracellular permeability was examined by measuring transepithelial
electrical resistance (TEER) in siRNA transient knockdown for both eIF4G1 and eIF4G2, and
shRNA-mediated knockdown for both eIF4G1 and eIF4G2. We found that TEER measurements
demonstrate that the transient knockdown of eIF4G1 in SK-CO15 monolayers fails to develop
the paracellular barrier and attenuates AJ and TJ assembly (figure 3.6). These findings agreed
with the result of the shRNA-mediated depletion of eIF4G1 and eIF4G2 which shows that both
depletion of eIF4G1 and eIF4G2 prevents the formation of the paracellular barrier in SK-CO15
cell lines (figure 3.7). Generally, these findings are supported previous studies which suggested
that the IBD and different intestinal and colorectal cancers increase the intestinal permeability
[12].

5.3 eIF4G isoforms localization.
The localization of translational initiation factors is considered as a significant mechanism by
which proteins were derived to their functional sites within cells [47]. Given previous studies
from various groups of researchers who found that the protein translation machinery localizes on
the leading edge of migrating fibroblasts [47, 50, 71], we want to investigate if similar actions
happen during migration of intestinal epithelial cell monolayers. The protein translation on the
leading edge was assessed by pulse-labeling of the cells with puromycin and immunolabeling of
newly-translated proteins with anti-puromycin mAb, [46] as shown in Figure 4.1. We confirmed
this result by the subsequent experiment which used wounded HIEC cell monolayers and we
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immunolabeled it for eIF4G2 using commercially available antibodies. We found that eIF4G2 is
localized on the cytoplasm of the leading edge of the migrating cell (figure 4.2B) compared to
the stationary cell which has eIF4G2 localized in the nucleus (figure 4.2A). This finding suggests
that the translation initiation machinery is active on the leading edge of migrating cells.

5.4 Pharmacological inhibitors and their roles in cell migration and regulating
the structure and permeability of model intestinal epithelial barriers.
There are several multiple inhibitors which either work by the interaction between eIF4G and
eIF4E or between the 5' cap of mRNA and eIF4E [52, 72, 73]. Ribavirin is one of the
pharmacological inhibitors, which is considered as antiviral drug and structurally mimics to 5'
cap of mRNA thus competing with eIF4E binding. It has been established through various
studies that Ribavirin attenuates the migration and invasion of lung and breast cancer cells in
vitro by reducing the wound closure. Also, this drug reduces the metastasis of pulmonary cancer
cells, and blocks the growth of tumor cells in vivo. Additionally, it suppresses the TGFB-induced
EMT and changes the shape of cells to be more epithelial-like round morphology in both
NSCLC and in breast cancer cell lines by downregulating the expression of mesenchymal
markers [74-76]. Another pharmacological inhibitor is eIF4E/eIF4G interaction inhibitor 1
(4EGI-1), which is considered as an antitumor agent. It works allosterically by binding to eIF4E
and prevents the interaction between eIF4E and eIF4G. Recent studies investigated the negative
role of 4EGI-1 in breast CSCs (cancer stem cells) by inhibiting their proliferation and invasion.
Also, 4EGI-1 inhibits breast CSC by inducing the apoptosis, and suppressing tumor angiogenesis
and tumor growth in vivo[73, 77, 78]. In our study, we examined the effects of Ribavirin and
4EGI-1 on the collective cell migration of intestinal epithelial monolayers, which involves HIEC
(poorly differentiated cells) and T84 (well differentiated cells). We found that both Ribavirin and
4EGI-1 decrease the collective cell migration in both cell lines compared to the control (figures
4.3 and 4.4). These findings agree with previous studies which indicate the negative role of
Ribavirin on cell migration[74, 76].
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5.5 eIF4G isoforms and their effect on motility, ECM adhesion, and
morphology of intestinal epithelial cells.
Depletion of eIF4G isoforms proteins in intestinal epithelial cells was found to result in
attenuated collective cell migration (fig. 4.5 and 4.6) and decreased transfilter migration of
individual cells (fig. 4.7). In the case of collective cell migration, there are two different results
depending on the type of intestinal epithelial cell lines. For the HIEC cells, which is stem-celllike, the collective cell migration significantly decreased in knockdown of only eIF4G2.
However, in T84 cell lines (well-differentiated cells), the wound closure was attenuated in
depletion of both eIF4G1 and eIF4G2. These results agree with previously published study
which reports that eIF4GI significantly attenuates the wound closure of NSCLC cell [74]. Our
findings regarding molecular mechanisms that underlie the inhibited migration of eIF4G
isoforms knockdown in intestinal epithelial cells created unsolved questions. The first
mechanism, loss of eIF4G1 or eIF4G2 can decrease cell motility via downregulation of different
FA proteins. Another mechanism is perhaps by inhibiting of Rac1 GTPase and its down-stream
kinase PAK1, which is known to phosphorylate paxillin along with Src and FAK [79]. Because
the ECM adhesion and cell spreading are the rate limiting steps of cell migration, we have
supported our finding results by examining the cell adhesion and cell spreading in HIEC cells.
We found that there is no change in the ECM adhesion over collagen type 1 in depletion of
eIF4G isoforms, whereas the cell spreading was significantly increased in eIF4G2 depletion (fig.
4.8 and 4.9). These findings maybe explain the decreased velocity of cell migration in HIEC
cells. In order to investigate if knockdown of eIF4G isoforms has an effect on EMT, we
examined the morphology of the confluent HIEC cells in shRNA-mediated knockdown of both
eIF4G1 and eIF4G2. We found that in the case of eIF4G1, the cells become more epithelial- like
rounded cells compared to control and eIF4G2 depletion, which appear as a more fibroblast-like
spindle shape (fig. 4.10A). Accordingly, we examined the expression of different myo-epithelial
markers by immunoblotting. We found that the decrease in the expression of myo-epithelial
markers, which involve alpha-SMA, L-caldesmon, and sm22, in eIF4G1 depletion. However,
there is no change in one of EMT marker vimentin (fig.4.10B). These findings are consistent
with the previous study which suggest that knockdown of eIF4G1 in NSCLC cell lines is
induced by changing the morphology of the cells to be more epithelial-like round
morphology[74].
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6. CONCLUSION
our study suggests that loss of intestinal epithelial eIF4G isoforms play essential roles in
disruption of the mucosal barrier by decreasing the expression of different AJs and TJs proteins;
and attenuating epithelial integrity and restitution by inducing disassembly of intestinal epithelial
TJs and AJs. Furthermore, the loss of eIF4G isoforms markedly attenuates epithelial wound
closure depending on the type of the cells. Also, the depletion of eIF4G isoforms decreases the
transfilter migration of individual cells. Finally, our studies have shown that knockdown of
eIF4G1 and eIF4G2 have no effect on ECM adhesion, whereas the depletion of eIF4G2 has a
positive effect on cell spreading by increasing the cell surface area. However, further studies
need to confirm this hypothesis.
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7. Future Directions
In order to study the effect of eIF4G isoforms depletion with different intestinal epithelial cell
lines, HIEC, HT-29, SK-CO15 and T84 with stable shRNA-mediated knockdown and lentiviral
CRISP/CAS9 knockout system of either eIF4G1 or eIF4G2 will be used to perform all the
mentioned assays in this thesis. Also, we will overexpress select AJ and TJ proteins (p120
catenin, E-cadherin, claudin-4, and some others) in eIF4G1 or eIF4G2-depleted epithelial cells
using an internal ribosomal entry site (IRES) to determine if overexpression of junctional
proteins can restore barrier function and junctional integrity in eIF4G- deficient cells.
Additionally, we want to elucidate if overexpression of eIF4G isoforms ameliorates cytokineinduced defects of apical junctions and disruption of the epithelial barrier. These gain of function
experiments have two major goals. One is to examine if the increased expression of eIF4G1 and
eIF4G2 can enhance normal epithelial barrier. The other goal is to demonstrate a causal role of
eIF4G isoform downregulation in the cytokine-induced breakdown of the model intestinal
epithelial barrier. Also, we are interested in determining the effects of chronic mucosal
inflammation on global protein translation and the translation initiation machinery, in vivo.
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